<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01605578</url>
  </required_header>
  <id_info>
    <org_study_id>C11-48</org_study_id>
    <secondary_id>2011-A01496-35</secondary_id>
    <nct_id>NCT01605578</nct_id>
  </id_info>
  <brief_title>Description of Abdominal and Gluteo-femoral Subcutaneous Adipose Tissue Cell Population in Women - GLUTAB</brief_title>
  <official_title>Description Des Populations Cellulaires Des Tissus Adipeux Sous-cutanés Abdominaux et glutéo-fémoraux Chez la Femme.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare, in healthy women, the adipose tissue composition&#xD;
      between abdomen and thigh and then determine whether differences exist independently of the&#xD;
      state of obesity.&#xD;
&#xD;
      The findings of this study may help to explain the mechanism contributing to a beneficial&#xD;
      role of gluteo-femoral fat contrasting with a deleterious role of abdominal fat on&#xD;
      cardiovascular and metabolic dysfunctions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the number and the phenotype of cells between abdominal and gluteo-femoral adipose tissue in women.</measure>
    <time_frame>There is no time frame. It's a comparison of adipose tissue composition between two locations, collected both at visit 2 (inclusion).</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Adipose Tissue</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsies</intervention_name>
    <description>Abdominal and gluteo-femoral subcutaneous adipose tissue biopsies</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women between 15 and 45 years old&#xD;
&#xD;
          -  with genital activity&#xD;
&#xD;
          -  stable weight during the previous 3 months&#xD;
&#xD;
          -  BMI from 20 to 28&#xD;
&#xD;
          -  regular menstrual cycles (28 +/- 2 days) during the previous 3 months&#xD;
&#xD;
          -  reliable means of contraception (systemic hormonal contraception, intrauterine&#xD;
             contraceptive device, tubal ligation)&#xD;
&#xD;
          -  using the same way of contraception during the previous 3 months&#xD;
&#xD;
          -  normal clinical examination&#xD;
&#xD;
          -  able to be compliant with the schedule of protocol assessments&#xD;
&#xD;
          -  willing and able to provide written informed consent&#xD;
&#xD;
          -  affiliated to a National Health Service&#xD;
&#xD;
          -  agreeing to being registered on the national file for subjects participating in&#xD;
             biomedical research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusions related to significant medical disturbances :&#xD;
&#xD;
          -  type I and II diabetes&#xD;
&#xD;
          -  early menopause&#xD;
&#xD;
          -  serious psychological disorders&#xD;
&#xD;
          -  uncontrolled thyroid disorders&#xD;
&#xD;
          -  know allergy to local anesthetics especially Xylocaine&#xD;
&#xD;
          -  abnormal laboratory results&#xD;
&#xD;
          -  medical history that, in the opinion of the investigator, makes the subject unsuitable&#xD;
             for enrollment&#xD;
&#xD;
          -  positive test result for HIV, HCV and/or HBV virus&#xD;
&#xD;
          -  positive pregnancy test&#xD;
&#xD;
          -  Exclusions related to subject lifestyle :&#xD;
&#xD;
          -  smoking &gt; 10 cigarettes per day&#xD;
&#xD;
          -  smoking cessation during the previous 3 months&#xD;
&#xD;
          -  weight fluctuation (&gt;3kg) during the previous 3 months&#xD;
&#xD;
          -  alcohol abuse&#xD;
&#xD;
          -  coffee or tea consumption &gt; 6 cups per day&#xD;
&#xD;
          -  high consumption of drinks comprising xanthine bases (&gt;0.5 liters/day)&#xD;
&#xD;
          -  consumption of drinks (water or herbal teas) &gt; 2 liters per day&#xD;
&#xD;
          -  Exclusions related to previous or concomitant treatments :&#xD;
&#xD;
          -  anticoagulant&#xD;
&#xD;
          -  neuroleptic or antidepressant&#xD;
&#xD;
          -  medication with draining, lipolytic, appetite suppressant and/or slimming effect&#xD;
&#xD;
          -  local or systemic corticosteroid therapy on the test areas&#xD;
&#xD;
          -  hormonal treatment other than contraception&#xD;
&#xD;
          -  diuretic&#xD;
&#xD;
          -  local treatment against cellulitis (mesotherapy,phosphatidylcholine injection,&#xD;
             mechanical process)&#xD;
&#xD;
          -  thighs liposuction &lt; 2 years&#xD;
&#xD;
          -  chronic treatment with anti-inflammatory&#xD;
&#xD;
          -  Exclusions related to the subject :&#xD;
&#xD;
          -  unwillingness or inability to comply with the requirements of the protocol&#xD;
&#xD;
          -  previous participation in a clinical trial within 30 days&#xD;
&#xD;
          -  inability to understand and sign the consent due to linguistic or psychic issues&#xD;
&#xD;
          -  subject deprived of liberty or under guardianship, tutorship or judicial protection&#xD;
&#xD;
          -  female who are currently pregnant or breastfeeding or female considering becoming&#xD;
             pregnant while in the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Thalamas, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Purpan (Toulouse)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claire Thalamas, Doctor</last_name>
    <phone>+33(0)561779103</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique, CHU Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Marquine</last_name>
      <phone>+33(0)561777638</phone>
    </contact>
    <investigator>
      <last_name>Claire Thalamas, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monique Galitzky, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabienne Calvas, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <study_first_submitted>May 11, 2012</study_first_submitted>
  <study_first_submitted_qc>May 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2012</study_first_posted>
  <last_update_submitted>May 21, 2012</last_update_submitted>
  <last_update_submitted_qc>May 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

